# LITHIUM CARBONATE
> **ANDA205663** · Abbreviated New Drug Application (Generic) · Sponsor: UNIQUE · Approved 2017-06-05
## Drug
- **FDA Application Number:** ANDA205663
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LITHIUM CARBONATE
- **Generic name:** LITHIUM CARBONATE
- **Active ingredients:** LITHIUM CARBONATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** UNIQUE
- **Manufacturer:** Rising Pharma Holdings, Inc.
- **First approval:** 2017-06-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205663)
---
*AI Analytics · CC0 1.0*